This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings by this filer, out of 25. Reading the whole list, and the company page behind every filing, is part of the subscription. So are this filer’s key figures — how many filings and open-market buys they reported, and over which period — the price beside each line, and the measured buy-following figure where there is one. What that costs is on the pricing page.
The most recent filings
5 of 25On an award the register reports a price of 0: nothing was paid, and the Quantity column shows the size.
| Company | Transaction | Reported |
|---|---|---|
| Pharming Group N.V.Chief Commerfcial Officer | Option exercisenothing paidquantity 23,720 | Aug 26, 2025 |
| Pharming Group N.V.Chief Commerfcial Officer | Administrative€22,534quantity 23,720 | Aug 26, 2025 |
| Pharming Group N.V.Chief Commerfcial Officer | Open-market sell€25,143quantity 23,720 | Aug 26, 2025 |
| Pharming Group N.V.Chief Commercial Officer | Option exercisenothing paidquantity 876,280 | Aug 22, 2025 |
| Pharming Group N.V.Chief Commercial Officer | Option exercise€832,466quantity 876,280 | Aug 22, 2025 |